Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor

Technology appraisal guidance
Reference number: TA195
Published: 25 August 2010

TA195 Rheumatoid arthritis - drugs for treatment after failure of a TNF inhibitor: Appendix A provisional matrix of stakeholders

TA195 Rheumatoid arthritis - drugs for treatment after failure of a TNF inhibitor: Appendix A provisional matrix of stakeholders

TA195 Rheumatoid arthritis - drugs for treatment after failure of a TNF inhibitor: Appendix A provisional matrix of stakeholders
15 July 2013
(42.26 Kb 12 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 11 July 2013